Elevance Health, Inc.
NYSEElevance Health heads into mid-August with an unusual dynamic: insiders buying aggressively into a stock that just took its biggest single-day earnings hit in recent memory, while short sellers use the recovery to trim their positions. The insider story is the week's most compelling angle. On July 17 — two days after the stock collapsed 12.6% on Q2 earnings — CEO Gail Boudreaux…
ELV cost to borrow doubles to 0.42% in one week, though still historically low; stock up 3.5% today to $391.24 as insider buying accelerates.
Elevance Health heads into mid-August with an unusual dynamic: insiders buying aggressively into a stock that just took its biggest single-day earnings hit in recent memory, while short sellers use the recovery to trim…
Elevance Health reported Q2 results on July 15, and the Street's pre-earnings conviction has rapidly translated into fresh target raises — the question now is whether the stock at $426.79 can close the remaining gap to…
Snapshot as of 19 Aug 2026
Elevance Health arrives at its July 15 Q2 print with analysts in a clear upgrading mood, but the stock has quietly given back ground since the previous article, putting the Street's conviction to the test. The most…
Elevance Health heads into its July 15 Q2 earnings release riding an 8% weekly gain, with the Street actively raising price targets and short sellers showing no meaningful conviction against the move. The analyst…
Elevance Health gave back ground this week, falling 6.3% to $397.80 — erasing the gains that had briefly carried the stock above its consensus mean target and putting options traders on edge just four weeks before the…
ELV has staged a sharp recovery this week, but the real story is what's happening on the Street — a wave of analyst target upgrades that has effectively validated the rebound and is still running ahead of where the…
Elevance Health arrives at mid-week with its most constructive analyst backdrop in months — and a stock up 24% in a single month that is finally starting to earn its valuation lift. The catalyst shaping this week's…
Elevance Health heads into its May 13 earnings report on the back of a sharp 21% one-month rally and a wave of analyst optimism — leaving the debate squarely about whether the recovery in managed care valuations has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELV — free to start on ORTEX.
Sign up for free →Open ELV on ORTEX